67.01 USD
↗ 1.54 (2.35%)AT CLOSE (11:59 AM EDT)
Bristol-Myers Squibb Co.
BMYNYSE • USD
67.06
↗ 0.05 (0.07%)
POST MARKET (AS OF 08:14 PM EDT)
Post Market
AS OF 08:14 PM EDT
67.06
↗ 0.05 (0.07%)
Market: CLOSED
Bristol-Myers Squibb Co. (BMY) trades at $67.01 per share. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. Key drivers include exceptional Return on Equity (41.6%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 21, 2026.
Open?$65.79
High?$67.55
Low?$65.13
Prev. Close?$65.47
Volume?7.9M
Avg. Volume?11.9M
VWAP?$66.68
Rel. Volume?0.67x
Bid / Ask
Bid?$67.00 × 100
Ask?$67.11 × 100
Spread?$0.11
Midpoint?$67.06
Valuation & Ratios
Market Cap?133.7B
Shares Out?2.0B
Float?2.0B
Float %?99.9%
P/E Ratio?14.41
P/B Ratio?5.99
EPS?$4.54
Dividend?3.81%
Ex-Dividend?N/A
News
Profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Themes
Address
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Phone: (609) 252-4621
PRINCETON, NJ 08543
Phone: (609) 252-4621
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?61
Momentum?77
Short Sent.?68
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.69Grey
Confidence?82%High
Short InterestModerate
Short % of Float?2.56%Low
Short Interest?52.3M
Days to Cover?4.6
Free Float2.0B
Avg Daily Volume11.3M
Settlement Date2026-07-31
Financial Health
Current Ratio?1.53Adequate
Quick Ratio?1.38Adequate
Cash Ratio?0.47Low
Debt/Equity?1.93High
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score89/100
P/E?14.4CHEAP▾
Peers100
S&P83
P/B?5.99FAIR▾
Peers90
S&P31
P/S?2.72CHEAP▾
Peers91
S&P54
P/FCF?11.7CHEAP▾
Peers91
S&P84
EV/EBITDA?11.3CHEAP▾
Peers91
S&P72
EV/Sales?3.42FAIR▾
Peers100
S&P55
Returns & Efficiency
ROE?41.6%STRONG▾
Peers67
S&P89
ROA?10.6%STRONG▾
Peers70
S&P76
Cash Flow & Enterprise
FCF?$11.4B
Enterprise Value?$168.1B
Fundamentals ratios updated end of day